Table 2 Results of nerve conduction studies in patients with Guillain–Barre syndrome
NerveDistal latency (ms)CMAP amplitude (mv)CV (m/s)F wave latency (ms)
Median (n = 102)
    UnrecordableNoneNoneNone36 (35.3%)
    Normal58 (56.9%)55 (53.9%)53 (51.9%)27 (26.4%)
    Abnormal44 (43.1%)47 (46.1%)49 (48.1%)39 (38.3%)
    Mean (SD)5.90 (3.92)2.83 (2.80)46.93 (13.41)33.61 (9.42)
Ulnar (n = 102)
    Unrecordable10 (9.8%)10 (9.8%)10 (9.8%)52 (51%)
    Normal34 (33.3%)35 (34.3%)54 (52.9%)18 (17.6%)
    Abnormal58 (56.9%)57 (55.9%)38 (37.3%)32 (31.4%)
    Mean (SD)4.60 (2.93)2.71 (2.37)47.77 (14.81)34.31 (8.99)
Common peroneal (n = 102)
    Unrecordable19 (18.6%)19 (18.6%)19 (18.6%)62 (60.8%)
    Normal23 (22.5%)69 (67.7%)61 (59.8%)36 (35.3)
    Abnormal60 (58.8%)14 (13.7%)22 (21.6%)4 (3.9%)
    Mean (SD)7.96 (3.26)1.83 (1.58)41.38 (9.16)51.98 (12.49)
  • CMAP, compound muscle action potential; CV, conduction velocity.